OpenAI IPO will not take place in 2026, Sam Altman says

Sam Altman's decision to delay OpenAI's IPO beyond 2026 reflects a shift in industry priorities. The company prioritizes safety and alignment over immediate public market access. This follows Anthropic's recent safety report detailing threat actors using Claude for dangerous research. The report cited attempts to research avian flu adaptations and gain-of-function research on the chikungunya virus.

For Asian AI companies, this delay points to increased scrutiny on safety protocols. Regulators in markets like Singapore and South Korea will likely intensify their focus on responsible AI development. Companies like Baidu and Alibaba, developing their own large language models, face pressure to demonstrate robust safety frameworks. The test for these firms is whether they can balance rapid innovation with public trust.

The thing to watch is how other major AI players respond. Anthropic had already filed paperwork for its own IPO. If Anthropic or other major players also delay their public offerings, it would confirm a broader industry pause. This would shift investor expectations for AI valuations in 2027 and beyond.